+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results



The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results



Canadian Anaesthetists' Society Journal 29(3): 218-221



In vitro caffeine contracture tests were carried out on whole rat muscle composed primarily of either histochemical type I or type II fibers. Muscles composed primarily of type I fibers developed contractures at lower concentrations of caffeine and had lower caffeine specific concentrations than muscles composed primarily of type II fibers. These findings indicate that the histochemical profile of a muscle can influence the results of the in-vitro caffeine contracture test.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 044659262

Download citation: RISBibTeXText

PMID: 7074401

DOI: 10.1007/bf03007119


Related references

The influence of the histochemical profile of muscle on the in vitro caffeine contracture test. Canadian Journal of Neurological Sciences 7(4): 327, 1980

Is resting membrane potential a possible indicator of viability of muscle bundles used in the in vitro caffeine contracture test?. Anesthesia and Analgesia 74(1): 105-111, 1992

Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. Journal of Anesthesia 14(1): 6, 2000

Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle. Acta Anaesthesiologica Scandinavica 40(4): 437-444, 1996

Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia. Canadian Anaesthetists' Society Journal 29(6): 550-562, 1982

Caffeine halothane contracture test and the gracilis muscle. Canadian Journal of Anaesthesia 40(5 Part 2): A16, 1993

The caffeine contracture test for malignant hyperthermia caffeine citrate caffeine benzoate or caffeine free base?. Acta Anaesthesiologica Scandinavica 35(6): 541-544, 1991

Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesthesia and Analgesia 69(4): 511-515, 1989

A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. Anesthesiology 75(1): 4-8, 1991

The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Canadian Anaesthetists' Society Journal 23(6): 624-635, 1976

A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene. British Journal of Anaesthesia 51(8): 753-756, 1979

Contracture test and histologic and histochemical analyses of muscle biopsy specimens from horses with exertional rhabdomyolysis. Journal of the American Veterinary Medical Association 196(7): 1077-1083, 1990

A blinded comparison of noninvasive in vivo phosphorus nmr spectroscopy and the in vitro halothane caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesthesia & Analgesia 72(1): 36-47, 1991

Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia. Anesthesiology 109(4): 625-628, 2008

A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility. Anesthesia and Analgesia 72(1): 36-47, 1991